Advertisement

Topics

Immune Therapy Improves Lung Cancer Patients Survival

03:40 EDT 17 Apr 2018 | The Scientist

Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.

Original Article: Immune Therapy Improves Lung Cancer Patients Survival

NEXT ARTICLE

More From BioPortfolio on "Immune Therapy Improves Lung Cancer Patients Survival"

Advertisement
Quick Search
Advertisement
Advertisement